JPRN-UMIN000020815招募中2 期
A phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in T3/T4a and/or lymph node-positive advanced adenocarcinoma of the esophagogastric junction - ESOX trial
Cancer Institute Hospital, Gastroenterological Chemotherapy Department0 个研究点目标入组 50 人开始时间: 2016年3月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active synchronous or metachronous malignancy, excepting for early stage cancers 2) Active infectious diseases 3) Uncontrollable HBV infection 4) Pregnant or lactation women, or women with the possibility of the pregnancy. 5) Severe mental disorders, neurological disease 6) under systemic steroid therapy 7) under treatment of flucytosine, phenytoin or warfarin potassium 8) Iodoallergy 9) Unstable angina, or myocardial infarction within 6 months. 10) Patients who are judged inappropriate for the entry into this study by the investigator.
研究者
相似试验
已完成
2 期
ESOX trialadenocarcinoma of the esophagogastric junctionJPRN-jRCTs051180192Watanabe Masayuki50
已完成
2 期
A phase II study of systemic chemotherapy with S-1 and Oxaliplatin followed by gastrectomy with D2 or D2 plus limited para-aortic lymph node dissection in HER2 negative advanced gastric or esophagogastric junction cancer with extensive lymph node metastasisGastric cancerJPRN-UMIN000027506Cancer Institute Hospital35
进行中（未招募）
2 期
SOX-D2 studyGastric CancerJPRN-jRCTs051180198Sano Takeshi35
已完成
不适用
A phase I/II study of chemotherapy using S-1, Oxaliplatin plus Irinotecan for unresectable pancreatic cancerunresectable pancreatic cancerJPRN-UMIN000014471Department of Gastroenterology Kitasato University School of Medicine25
招募中
2 期
Phase II study of perioperative chemotherapy for cStage II and III thoracic esophageal canceresophageal cancerJPRN-jRCTs051200048Kitadani Junya27